ArticleAmerican journal of public health2016
Continuing Versus New Prescriptions for Sedative-Hypnotic Medications: United States, 2005-2012.
Article in American journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 29 citations in OpenAlex.
- Development and pilot evaluation of an electronic trigger-based surveillance model for sedative-hypnotic drug misuse in a tertiary hospital.Scientific reports · 2026Article
- Diagnosis, treatment, and associated outcomes of later-life insomnia: a narrative review.Sleep · 2025Review
- 'Let's talk about sleep health' within primary care: a qualitative study of patients' willingness to engage in psychological interventions for insomnia.The British journal of general practice : the journal of the Royal College of General Practitioners · 2024Article
- Article
- Examining Adult Patients' Success with Discontinuing Long-term Benzodiazepine Use: a Qualitative Study.Journal of general internal medicine · 2024Article
- Potentially Harmful Medication Prescribing by the Degree of Physician Specialization in Nursing Home Practice: An Observational Study.Journal of the American Medical Directors Association · 2023Observational
- Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study.BMC pharmacology & toxicology · 2023Article
- Declining trend in use of medications for sleep disturbance in the United States from 2013 to 2018.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022Article
- Association Between the Use of Non-benzodiazepine Hypnotics and Cognitive Outcomes: A Systematic Review.Current sleep medicine reports · 2020Article
- The medicalization of sleeplessness: Results of U.S. office visit outcomes, 2008-2015.SSM - population health · 2019Article
- Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.Journal of general internal medicine · 2018Article
- Long-Term Use of Benzodiazepines and Nonbenzodiazepine Hypnotics, 1999-2014.Psychiatric services (Washington, D.C.) · 2018Article
- Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.Journal of the American Geriatrics Society · 2017Article
- Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.JAMA psychiatry · 2017Article
- What do hypnotics cost hospitals and healthcare?F1000Research · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
objectivesTo assess trends in continuing and new prescriptions for sedative-hypnotic medications, including benzodiazepines (BZDs) and non-BZD receptor agonists (nBZRAs).
methodsData came from the National Ambulatory Medical Care Survey and comprised 287 288 randomly sampled patient visits. Physicians reported medications prescribed and whether they were "continuing" or "new" prescriptions. We assessed trends in continuing BZD, new BZD, continuing nBZRA, and new nBZRA prescriptions from 2005 to 2012.
resultsProportions of visits with continuing prescriptions increased from 3.4% in 2005 to 4.7% in 2012 (P < .01) for BZDs, and from 1.0% to 1.7% (P < .01) for nBZRAs. We noted no changes in new prescriptions. We observed the same patterns across patient age and physician specialties, except psychiatry. Despite no growth over time, the prevalence of visits involving continuing and new BZD and nBZRA prescriptions was much higher in psychiatry than in primary care and other specialties.
conclusionsIncreased sedative-hypnotic prescribing in recent years may be attributable to long-term growth in continuing prescriptions, rather than new prescriptions. Public Health Implications. Findings call for renewed efforts to limit continuing prescribing of sedative-hypnotics to reduce their use in the population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.